These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 24856529)
1. Molecular diagnosis of tuberculosis and drug resistance. Lin SY; Desmond EP Clin Lab Med; 2014 Jun; 34(2):297-314. PubMed ID: 24856529 [TBL] [Abstract][Full Text] [Related]
2. GeneXpert: A new tool for the rapid detection of rifampicin resistance in mycobacterium tuberculosis. Saeed M; Iram S; Hussain S; Ahmed A; Akbar M; Aslam M J Pak Med Assoc; 2017 Feb; 67(2):270-274. PubMed ID: 28138184 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance. Wilson ML Clin Infect Dis; 2011 Jun; 52(11):1350-5. PubMed ID: 21596676 [TBL] [Abstract][Full Text] [Related]
4. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance. Alcaide F; Coll P Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():34-40. PubMed ID: 21420565 [TBL] [Abstract][Full Text] [Related]
5. Tuberculosis drug resistance testing by molecular methods: opportunities and challenges in resource limited settings. Abebe G; Paasch F; Apers L; Rigouts L; Colebunders R J Microbiol Methods; 2011 Feb; 84(2):155-60. PubMed ID: 21129417 [TBL] [Abstract][Full Text] [Related]
6. Rapid diagnosis of Mycobacterium tuberculosis infection and drug susceptibility testing. Wilson ML Arch Pathol Lab Med; 2013 Jun; 137(6):812-9. PubMed ID: 23721277 [TBL] [Abstract][Full Text] [Related]
7. DNA probe based colorimetric method for detection of rifampicin resistance of Mycobacterium tuberculosis. Adikaram CP; Perera J; Wijesundera SS J Microbiol Methods; 2014 Jan; 96():92-8. PubMed ID: 24275535 [TBL] [Abstract][Full Text] [Related]
8. Comment on: isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing. Köser CU; Summers DK; Archer JA J Antimicrob Chemother; 2011 Mar; 66(3):686-7; author reply 687. PubMed ID: 21177677 [No Abstract] [Full Text] [Related]
9. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay. Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071 [TBL] [Abstract][Full Text] [Related]
10. Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis. Palomino JC FEMS Immunol Med Microbiol; 2009 Jul; 56(2):103-11. PubMed ID: 19416361 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of GeneXpert MTB/RIF for the detection of Mycobacterium tuberculosis and resistance to rifampin in clinical specimens. Bunsow E; Ruiz-Serrano MJ; López Roa P; Kestler M; Viedma DG; Bouza E J Infect; 2014 Apr; 68(4):338-43. PubMed ID: 24296493 [TBL] [Abstract][Full Text] [Related]
12. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs. Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034 [TBL] [Abstract][Full Text] [Related]
13. The management of tuberculosis: epidemiology, resistance and monitoring. Bang D Dan Med Bull; 2010 Nov; 57(11):B4213. PubMed ID: 21055374 [TBL] [Abstract][Full Text] [Related]
14. [Rapid detection of rifampin resistance of Mycobacterium tuberculosis using high-throughput pyrosequencing technique]. Zhao JR; Bai YJ; Wang Y; Zhang QH; Luo M; Yan XJ Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):297-300. PubMed ID: 15949307 [TBL] [Abstract][Full Text] [Related]
15. Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how? Trébucq A; Enarson DA; Chiang CY; Van Deun A; Harries AD; Boillot F; Detjen A; Fujiwara PI; Graham SM; Monedero I; Rusen ID; Rieder HL Int J Tuberc Lung Dis; 2011 Dec; 15(12):1567-72. PubMed ID: 22005110 [TBL] [Abstract][Full Text] [Related]
16. [The present and future prospects in rapid molecular diagnosis of tuberculosis and MDR-TB (First Part)]. Tănăsescu M; Didilescu C; Marica C Pneumologia; 2013; 62(3):134-8. PubMed ID: 24273995 [TBL] [Abstract][Full Text] [Related]
17. An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis. Williamson DA; Basu I; Bower J; Freeman JT; Henderson G; Roberts SA Diagn Microbiol Infect Dis; 2012 Oct; 74(2):207-9. PubMed ID: 22819240 [TBL] [Abstract][Full Text] [Related]
18. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid? Velayati AA; Farnia P; Masjedi MR; Hoffner S Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176 [No Abstract] [Full Text] [Related]
19. The TDR Tuberculosis Strain Bank: a resource for basic science, tool development and diagnostic services. Vincent V; Rigouts L; Nduwamahoro E; Holmes B; Cunningham J; Guillerm M; Nathanson CM; Moussy F; De Jong B; Portaels F; Ramsay A Int J Tuberc Lung Dis; 2012 Jan; 16(1):24-31. PubMed ID: 22236841 [TBL] [Abstract][Full Text] [Related]
20. Defining threshold values in microscopic examination and qPCR for optimal performance of line probe assays for resistance detection in Mycobacterium tuberculosis complex. Wagner K; Preiswerk B; Keller PM; Schulthess B Diagn Microbiol Infect Dis; 2019 Oct; 95(2):159-161. PubMed ID: 31279584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]